NCT04405596: Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia
- State
- Not started
- Phase
- Phase 1 and Phase 2
- People
- 15 planned
- Started
- Jan 2025
- Primary completion
- Jan 2026
- Arms
- Ambroxol
- Results
- None posted
- 28 May 2020: Trial registered